4//SEC Filing
SAYARE MITCHEL 4
Accession 0001012975-18-000023
CIK 0001326190other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:54 PM ET
Size
5.5 KB
Accession
0001012975-18-000023
Insider Transaction Report
Form 4
SAYARE MITCHEL
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2017-12-29$1.95/sh+5,100$9,963→ 32,650 total(indirect: See Footnote)
Footnotes (2)
- [F1]The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $1.91 to $1.98 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
- [F2]The shares of Common Stock are owned directly by the Mitchel Sayare 2010 Trust. The Reporting Person, as sole trustee of the Mitchel Sayare 2010 Trust, may be deemed to be the beneficial owner of the securities held by the Mitchel Sayare 2010 Trust. The Reporting Person disclaims beneficial ownership of the securities held by the Mitchel Sayare 2010 Trust except to the extent of his pecuniary interest therein.
Documents
Issuer
Altimmune, Inc.
CIK 0001326190
Entity typeother
Related Parties
1- filerCIK 0001201196
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:54 PM ET
- Size
- 5.5 KB